These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 33598975)

  • 1. Longitudinal Changes of Circulating miRNAs During Bisphosphonate and Teriparatide Treatment in an Animal Model of Postmenopausal Osteoporosis.
    Weigl M; Kocijan R; Ferguson J; Leinfellner G; Heimel P; Feichtinger X; Pietschmann P; Grillari J; Zwerina J; Redl H; Hackl M
    J Bone Miner Res; 2021 Jun; 36(6):1131-1144. PubMed ID: 33598975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA levels in bone and blood change during bisphosphonate and teriparatide therapy in an animal model of postmenopausal osteoporosis.
    Kocijan R; Weigl M; Skalicky S; Geiger E; Ferguson J; Leinfellner G; Heimel P; Pietschmann P; Grillari J; Redl H; Hackl M
    Bone; 2020 Feb; 131():115104. PubMed ID: 31683019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum microRNAs as novel biomarkers for osteoporotic vertebral fractures.
    Zarecki P; Hackl M; Grillari J; Debono M; Eastell R
    Bone; 2020 Jan; 130():115105. PubMed ID: 31669252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Profile of microRNAs Linked to Bone Metabolism During Sequential Treatment for Postmenopausal Osteoporosis.
    Yavropoulou MP; Anastasilakis AD; Makras P; Papatheodorou A; Rauner M; Hofbauer LC; Tsourdi E
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32521543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-210 improves postmenopausal osteoporosis in ovariectomized rats through activating VEGF/Notch signaling pathway.
    Ren LJ; Zhu XH; Tan JT; Lv XY; Liu Y
    BMC Musculoskelet Disord; 2023 May; 24(1):393. PubMed ID: 37198572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNA Signatures in Patients With Idiopathic and Postmenopausal Osteoporosis and Fragility Fractures.
    Kocijan R; Muschitz C; Geiger E; Skalicky S; Baierl A; Dormann R; Plachel F; Feichtinger X; Heimel P; Fahrleitner-Pammer A; Grillari J; Redl H; Resch H; Hackl M
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4125-4134. PubMed ID: 27552543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating miRNAs Respond to Denosumab Treatment After 2 Years in Postmenopausal Women With Osteoporosis-the MiDeTe study.
    Messner Z; Carro Vázquez D; Haschka J; Grillari J; Resch H; Muschitz C; Pietschmann P; Zwerina J; Hackl M; Kocijan R
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1154-1165. PubMed ID: 36408612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mir-381-3p aggravates ovariectomy-induced osteoporosis by inhibiting osteogenic differentiation through targeting KLF5/Wnt/β-catenin signaling pathway.
    Zhao Y; Liu J; Zhang Y; Liang M; Li R; Song Y; Wang Y
    J Orthop Surg Res; 2024 Aug; 19(1):480. PubMed ID: 39152444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of resveratrol on estrogen deficiency-induced osteoporosis though attenuating NADPH oxidase 4/nuclear factor kappa B pathway by increasing miR-92b-3p expression.
    Zhang Y; Liu MW; He Y; Deng N; Chen Y; Huang J; Xie W
    Int J Immunopathol Pharmacol; 2020; 34():2058738420941762. PubMed ID: 32674689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in Serum Exosomes as Circulating Biomarkers for Postmenopausal Osteoporosis.
    Shi H; Jiang X; Xu C; Cheng Q
    Front Endocrinol (Lausanne); 2022; 13():819056. PubMed ID: 35360081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating miR-181c-5p and miR-497-5p Are Potential Biomarkers for Prognosis and Diagnosis of Osteoporosis.
    Ma J; Lin X; Chen C; Li S; Zhang S; Chen Z; Li D; Zhao F; Yang C; Yin C; Qiu W; Xiao Y; Zhang K; Miao Z; Yang T; Qian A
    J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 31872255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone-related Circulating MicroRNAs miR-29b-3p, miR-550a-3p, and miR-324-3p and their Association to Bone Microstructure and Histomorphometry.
    Feichtinger X; Muschitz C; Heimel P; Baierl A; Fahrleitner-Pammer A; Redl H; Resch H; Geiger E; Skalicky S; Dormann R; Plachel F; Pietschmann P; Grillari J; Hackl M; Kocijan R
    Sci Rep; 2018 Mar; 8(1):4867. PubMed ID: 29559644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating serum microRNAs including senescent miR-31-5p are associated with incident fragility fractures in older postmenopausal women with type 2 diabetes mellitus.
    Heilmeier U; Hackl M; Schroeder F; Torabi S; Kapoor P; Vierlinger K; Eiriksdottir G; Gudmundsson EF; Harris TB; Gudnason V; Link TM; Grillari J; Schwartz AV
    Bone; 2022 May; 158():116308. PubMed ID: 35066213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulated microRNA-199a-3p enhances osteogenic differentiation of bone marrow mesenchymal stem cells by targeting Kdm3a in ovariectomized rats.
    Wu JC; Sun J; Xu JC; Zhou ZY; Zhang YF
    Biochem J; 2021 Feb; 478(4):721-734. PubMed ID: 33410908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of Circulating MicroRNAs in Response to Treatment With Teriparatide or Denosumab in Postmenopausal Osteoporosis.
    Anastasilakis AD; Makras P; Pikilidou M; Tournis S; Makris K; Bisbinas I; Tsave O; Yovos JG; Yavropoulou MP
    J Clin Endocrinol Metab; 2018 Mar; 103(3):1206-1213. PubMed ID: 29309589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-148a the epigenetic regulator of bone homeostasis is increased in plasma of osteoporotic postmenopausal women.
    Bedene A; Mencej Bedrač S; Ješe L; Marc J; Vrtačnik P; Preželj J; Kocjan T; Kranjc T; Ostanek B
    Wien Klin Wochenschr; 2016 Dec; 128(Suppl 7):519-526. PubMed ID: 27900532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the MicroRNA Profile of the Mandible of Ovariectomized Mice.
    Hao L; Li J; Tian Y; Wu J
    Cell Physiol Biochem; 2016; 38(4):1267-87. PubMed ID: 27008088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a bisphosphonate and selective estrogen receptor modulator on bone remodeling in streptozotocin-induced diabetes and ovariectomized rat model.
    Lee YS; Gupta R; Kwon JT; Cho DC; Seo YJ; Seu SY; Park EK; Han I; Kim CH; Sung JK; Kim KT
    Spine J; 2018 Oct; 18(10):1877-1887. PubMed ID: 29793000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats.
    Baumann BD; Wronski TJ
    Bone; 1995 Feb; 16(2):247-53. PubMed ID: 7756054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment.
    Anastasilakis AD; Polyzos SA; Makras P; Gkiomisi A; Sakellariou G; Savvidis M; Papatheodorou A; Kokkoris P; Terpos E
    Expert Opin Ther Targets; 2015 Mar; 19(3):299-306. PubMed ID: 25395071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.